Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RABBIT 2 Surgery: Basal-Bolus vs Sliding Scale Insulin in T2DM
NCT00596687Phase 4Completed
- Sponsor
- Emory University
- Start
- Dec 2007
- Primary completion
- Dec 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine and insulin glulisine in type 2 diabetes mellitus (T2DM) and hyperglycemia, sponsored by Emory University. Primary endpoint: Mean Blood Glucose Concentration. Started Dec 2007; status: completed.
02
Drugs
insulin glargineinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)hyperglycemia
Beyond the preview
Go deeper on NCT00596687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596687.